India has been one of the major global players in the development of generic drugs, continues to gain visibility in the development of new drugs, and is one of the major geographies for conducting multinational clinical trials. Learn how intergovernmental initiatives and partnerships between India's Drug Regulatory Department (DCGI office) and USFDA, Health Canada, MHRA and EMEA would add to India's role in the development of new medicines.
DIA Webinar: Worldwide Regulatory Landscape: Current Regulatory Initiatives in the US, Canada and EU
15 July 2009, United States
Introduction
Venue
Webinar
Webinar, United States
Useful links
Organised by
DIA - Drug Information Association
Contact information
Ms JoAnn Boileau
800 Enterprise Rd., #200, Horsham, PA, United States of America
+ 1-215-442-6175
Contact us by email
800 Enterprise Rd., #200, Horsham, PA, United States of America
+ 1-215-442-6175
Contact us by email
Search
Advertisement
Spotlight
Explore
Membership
